NEW DELHI, INDIA — July 17, 2026 — In a major breakthrough for regenerative medicine, Dr Batra’s® Healthcare has announced the launch of HairGain, India’s first advanced hair regrowth treatment powered by 50 billion exosomes. This innovative, non-surgical therapy brings one of the world’s most promising regenerative technologies to millions of Indians seeking an effective, science-backed solution for hair loss.
With an estimated 150 million people in India experiencing hair thinning and baldness across various age groups, hair loss has evolved from a cosmetic issue to a widespread emotional concern. From hereditary balding and stress-induced shedding to post-pregnancy and menopause-related hair thinning, consumers are increasingly seeking clinical treatments that do more than just manage hair fall—they want therapies that actively promote natural regrowth.
The Science Behind HairGain Unlike traditional treatments, HairGain is formulated to deliver powerful biological signals directly to the scalp. At its core is a standardized dose of 50 billion exosomes—microscopic cellular messengers vital for tissue regeneration and cell-to-cell communication. These exosomes work rapidly to awaken dormant hair follicles, initiate cellular repair, and foster an optimal scalp environment for robust hair growth.
The therapy is built on Dr Batra’s® proprietary TriXo Complex, a multi-dimensional regenerative formula. This complex combines the exosomes with scientifically proven ingredients, including:
-
PDRN (Polydeoxyribonucleotide)
-
Collagen & Caffeine
-
Growth Factors & Polypeptides
-
Copper Tripeptides
Working synergistically, these ingredients improve scalp microcirculation, strengthen the protective scalp barrier, and extend the active growth phase of the hair cycle.
Faster, Standardized Results Under clinical guidance, HairGain patients can expect to see visible improvements in approximately 75 days. Anticipated results include reduced hair fall, stronger roots, enhanced hair density, and noticeable new growth.
Dr. Akshay Batra, Vice-Chairman and Managing Director of Dr Batra’s® Healthcare, and the first Indian President of the Trichological Society of London (UK), emphasized the significance of this launch:
“Hair restoration is entering a completely new era. Today’s consumers are looking for solutions that are backed by science, are minimally invasive and capable of delivering meaningful hair regrowth by working with the body’s own regenerative mechanisms. Exosome therapy represents one of the most exciting advances in regenerative medicine because it delivers powerful biological signals that help awaken dormant hair follicles and support natural hair growth.”
Dr. Batra also highlighted the treatment’s distinct advantages over existing therapies like Platelet-Rich Plasma (PRP). “Unlike PRP, where results can vary depending on the quality and concentration of an individual’s own platelets, HairGain delivers a standardized dose of 50 Billion Exosomes, ensuring a far more consistent regenerative stimulus for the scalp,” he noted.
For individuals in the early to moderate stages of hair loss, HairGain presents a compelling non-surgical alternative that can restore hair naturally, potentially delaying or eliminating the need for invasive procedures like hair transplants.
About Dr Batra’s® Healthcare With a legacy spanning over four decades, Dr Batra’s® Healthcare operates more than 200 clinics across 130 cities in 10 countries, including India, the UK, and the UAE. Boasting a team of over 350 specialized doctors, the brand continues to pioneer accessible, next-generation healthcare therapies across hair, skin, and holistic wellness. For more information, visit www.drbatras.com.